Yahoo Search Busca da Web

Resultado da Busca

  1. Dissecting the Prediagnostic Journey to Identify Opportunities for Early Detection of Esophageal Cancer: Findings From a High-Risk Area in Rural China. Yu He et al. View ALL. Explore the first articles from the newest JCO Journal. Read JCO Oncology Advances.

    • Newest Content

      ORIGINAL REPORTS. Epilepsia Partialis Continua as a Sequelae...

    • About

      JCO GO aims to provide a home for high-quality literature...

  2. 9 de mai. de 2024 · ORIGINAL REPORTS. Epilepsia Partialis Continua as a Sequelae of Measles Infection in Children With Hematolymphoid Malignancies. COMMENTARIES May 02, 2024. Perspective: The COVID-19 Pandemic: Closing Borders, Opening Doors, and Breaking Ground on the Potential for Clinical Trial Access in Developing Countries Like Trinidad and Tobago.

  3. 9 de jun. de 2023 · JCO GO aims to provide a home for high-quality literature that fulfills a growing need for content describing the array of challenges faced by health care professionals in resource-constrained settings.

  4. JCO Global Oncology is a peer-reviewed open-access medical journal covering cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources. It was established in 2015 as the Journal of Global Oncology, obtaining its current name in 2020.

  5. JCO Global Oncology publishes high-quality literature on cancer care, research, and delivery issues in resource-constrained settings. It is an online-only journal with a H-index of 39 and a SJR of 1.302 in 2021.

  6. 21 de jan. de 2021 · JCO Global Oncology is a peer-reviewed, online journal that publishes articles on oncology, cancer and health services in low and middle income countries. The journal charges article processing fees and uses CC BY or CC BY-NC-ND licenses.

  7. 10 de nov. de 2022 · A new JCO Global Oncology (JCO GO) Special Series, “Driving Innovation to Advance Cancer Care Equity,” illustrates how innovation is making significant strides in securing better access to the technologies and approaches that will have a positive impact on cancer control and health equity across the globe.